approval · primary record
SODIUM BICARBONATE
2 approval events · latest 2026-10-06
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2026-10-06 |
| Approval events | 2 |
| Brand | SODIUM BICARBONATE |
| Sponsor | BAXTER HLTHCARE CORP |
| Route | INTRAVENOUS |
Approval history
2 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2026-10-06 | FDA | NDA | SODIUM BICARBONATE | BAXTER HLTHCARE CORP | INTRAVENOUS |
| 2026-07-09 | FDA | NDA | SODIUM BICARBONATE | AMNEAL | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:29:54.069Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:sodium-bicarbonate
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Sodium Bicarbonate · compound